Overexpression of interleukin-15 compromises CD4-dependent adaptive immune responses against herpes simplex virus 2

Journal of Virology

Volumn 83, Issue 2, 2009, Pages 918-926

  Gill, Navkiran ^a   Ashkar, Ali A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 15; RAG1 PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; ENVIRONMENT; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; IMMUNE RESPONSE; IMMUNIZATION; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENITALIA; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; IMMUNIZATION, PASSIVE; INTERLEUKIN-15; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCOUS MEMBRANE; SURVIVAL ANALYSIS;

HUMAN HERPESVIRUS 2; MUS;

EID: 58149517706     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01282-08     Document Type: Article

References (44)

1. Ashkar, A. A., S. Bauer, W. J. Mitchell, J. Vieira, and K. L. Rosenthal. 2003. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J. Virol. 77:8948-8956.
2. Ashkar, A. A., and K. L. Rosenthal. 2003. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77:10168-10171.
3. + T cells. J. Immunol. 170:5018-5026.
4. Braun, R. P., L. G. Payne, and L. Dong. 2006. Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes. Virol. J. 3:54.
5. Dalloul, A., E. Oksenhendler, O. Chosidow, P. Ribaud, G. Carcelain, S. Louvet, P. Massip, P. Lebon, and B. Autran. 2004. Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood. J. Clin. Virol. 30:329-336.
6. Docherty, J. J., M. A. Lohse, M. F. Dellaria, F. P. Naugle, C. W. Mason, R. A. Knerr, H. M. McDermott, F. K. Mundon, and D. H. Zimmerman. 1984. Incidence of herpes simplex virus types 1 and 2 in penile lesions of college men. J. Med. Virol. 13:163-170.
7. Dumais, N., A. Patrick, R. B. Moss, H. L. Davis, and K. L. Rosenthal. 2002. Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge. J. Infect. Dis. 186:1098-1105.
8. Fehniger, T. A., and M. A. Caligiuri. 2001. Interleukin 15: biology and relevance to human disease. Blood 97:14-32.
9. + T cells. J. Exp. Med. 193:219-231.
10. Fehniger, T. A., K. Suzuki, J. B. VanDeusen, M. A. Cooper, A. G. Freud, and M. A. Caligiuri. 2001. Fatal leukemia in interleukin-15 transgenic mice. Blood Cells Mol. Dis. 27:223-230.
11. Gallichan, W. S., R. N. Woolstencroft, T. Guarasci, M. J. McCluskie, H. L. Davis, and K. L. Rosenthal. 2001. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J. Immunol. 166:3451-3457.
12. Gill, N., and A. A. Ashkar. 2007. Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15. Eur. J. Immunol. 37:2529-2538.
13. Gill, N., P. M. Deacon, B. Lichty, K. L. Mossman, and A. A. Ashkar. 2006. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. J. Virol. 80:9943-9950.
14. Gill, N., K. L. Rosenthal, and A. A. Ashkar. 2005. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. J. Virol. 79:4470-4478.
15. Giri, J. G., S. Kumaki, M. Ahdieh, D. J. Friend, A. Loomis, K. Shanebeck, R. DuBose, D. Cosman, L. S. Park, and D. M. Anderson. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 14:3654-3663.
16. Gosselin, J., A. TomoIu, R. C. Gallo, and L. Flamand. 1999. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood 94:4210-4219.
17. + T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J. Gen. Virol. 82:845-853.
18. Harle, P., V. Cull, L. Guo, J. Papin, C. Lawson, and D. J. Carr. 2002. Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection. Antivir. Res. 56:39-49.
19. Herbst, M. M., and R. B. Pyles. 2003. Immunostimulatory CpG treatment for genital HSV-2 infections. J. Antimicrob. Chemother. 52:887-889.
20. Hiromatsu, T., T. Yajima, T. Matsuguchi, H. Nishimura, W. Wajjwalku, T. Arai, Y. Nimura, and Y. Yoshikai. 2003. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis. J. Infect. Dis. 187:1442-1451.
21. Kagimoto, Y., H. Yamada, T. Ishikawa, N. Maeda, F. Goshima, Y. Nishiyama, M. Furue, and Y. Yoshikai. 2008. A regulatory role of interleukin 15 in wound healing and mucosal infection in mice. J. Leukoc. Biol. 83:165-172.
22. Koelle, D. M., C. M. Posavad, G. R. Barnum, M. L. Johnson, J. M. Frank, and L. Corey. 1998. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Investig. 101:1500-1508.
23. Kwant, A., and K. L. Rosenthal. 2004. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2. Vaccine 22:3098-3104.
24. Lee, J. M., C. Y. Chung, W. W. Chiang, Y. H. Liou, C. F. Chen, and N. S. Liao. 2004. IL-15Rα is a negative regulator of TCR-activated proliferation in CD4 T cells. J. Immunol. 173:3155-3164.
25. Liu, K., M. Catalfamo, Y. Li, P. A. Henkart, and N. P. Weng. 2002. IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8 memory T cells. Proc. Natl. Acad. Sci. USA 99:6192-6197.
26. Lu, J., R. L. Giuntoli II, R. Omiya, H. Kobayashi, R. Kennedy, and E. Celis. 2002. Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes. Clin. Cancer Res. 8:3877-3884.
27. + T cells. J. Virol. 69:4711-4716.
28. McDermott, M. R., C. H. Goldsmith, K. L. Rosenthal, and L. J. Brais. 1989. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. J. Infect. Dis. 159:460-466.
29. Milligan, G. N., and D. I. Bernstein. 1995. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology 212:481-489.
30. Milligan, G. N., and D. I. Bernstein. 1997. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229:259-268.
31. Parr, M. B., and E. L. Parr. 1998. Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J. Virol. 72:2677-2685.
32. Parr, M. B., and E. L. Parr. 1999. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice. Virology 258:282-294.
33. + memory T cells are IL-15 dependent. J. Exp. Med. 204:951-961.
34. Schluns, K. S., K. Williams, A. Ma, X. X. Zheng, and L. Lefrancois. 2002. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168:4827-4831.
35. Stanberry, L., A. Cunningham, G. Mertz, A. Mindel, B. Peters, M. Reitano, S. Sacks, A. Wald, S. Wassilew, and P. Woolley. 1999. New developments in the epidemiology, natural history and management of genital herpes. Antivir. Res. 42:1-14.
36. Svensson, A., I. Nordstrom, J. B. Sun, and K. Eriksson. 2005. Protective immunity to genital herpes simpex (sic) virus type 2 infection is mediated by T-bet. J. Immunol. 174:6266-6273.
37. Toka, F. N., and B. T. Rouse. 2005. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-herpes simplex virus immunity. J. Leukoc. Biol. 78:178-186.
38. + T cells protect IL-2 receptor alpha-deficient mice from systemic infection with herpes simplex virus type 2. J. Immunol. 165:4552-4560.
39. Umemura, M., H. Nishimura, K. Hirose, T. Matsuguchi, and Y. Yoshikai. 2001. Overexpression of IL-15 in vivo enhances protection against Mycobacterium bovis bacillus Calmette-Guerin infection via augmentation of NK and T cytotoxic 1 responses. J. Immunol. 167:946-956.
40. Umemura, M., H. Nishimura, T. Yajima, W. Wajjwalk, T. Matsuguchi, M. Takahashi, Y. Nishiyama, M. Makino, Y. Nagai, and Y. Yoshikai. 2002. Overexpression of interleukin-15 prevents the development of murine retrovirus-induced acquired immunodeficiency syndrome. FASEB J. 16:1755-1763.
41. + T cells following a microbe exposure. J. Immunol. 168:1198-1203.
42. + T cells in IL-15 transgenic mice are involved in early protection against a primary infection with Listeria monocytogenes. Eur. J. Immunol. 31:757-766.
43. + CTL after reinfection. J. Immunol. 174:3590-3597.
44. + T cells, which are increased in active rheumatoid arthritis. Clin. Immunol. 124:328-335.